- Cardiology >
- Cardiovascular surgery >
- Occlusion device
Occlusion devices
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}

MemoCarna® Atrial Septal Defect (ASD) Occluder MemoCarna® Atrial Septal Defect Occluder Detail Adopts unique Dature-shape braiding technology, achieves faster endothelization with more flat disk after releasing and decreasing influences ...
Lepu Medical Technology

MemoPart™ Atrial Septal Defect (ASD) Occluder Atrial Septal Defect (ASD) Occluder Detail Modified rigidity and flexibility for different type of occluders - greater stiffness of ASDO offers excellent supporting force for big disks. ...
Lepu Medical Technology

MemoPart™ Ventricular Septal Defect (VSD) Occluder MemoPart™ VSD Occluder Detail Modified rigidity and flexibility for different type of occluders - less stiffness of VSDO reduces the holding force to minimize the risk of third ...
Lepu Medical Technology

... Detail Modified rigidity and flexibility for different type of occluders - balanced stiffness of PDAO ensures the optimal occlusion performance. Uniform and smooth oxide film on nitinol wire effectively prevents from ...
Lepu Medical Technology

MemoPart™ Patent Foramen Ovale (PFO) Occluder MemoPart™ Patent Foramen Ovale PFO Occluder Detail Features • Modified rigidity and flexibility for different type of occluders - greater stiffness of PFOO offers excellent supporting ...
Lepu Medical Technology

MemoLefort®Left Atrial Appendage Occluders System MemoLefort® Left Atrial Appendage Occluders System Detail • Self-expanding nitinol self-centering scaffold, providing excellent conformity, applicable to more than 98.5% anatomic ...
Lepu Medical Technology

... conformable device not previously available for larger ASDs, which typically have a greater risk for complications like pulmonary hypertension, right heart enlargement, or atrial fibrillation. The ability to retrieve ...
Gore

... transcatheter closure of ostium secundum atrial septal defects (ASDs). It's delivery system allows easy deployment of the device via standard femoral venous access. It is a safe and effective non-surgical options for ...
Gore

Hyperion™ Atrial Septal Defect Occluder The Hyperion™ self-expandable ASD double disc occluder is a percutaneous trans catheter device intended for the closure of atrial septum defects (ASD), and/or for patients who ...
Comed

The Hyperion™ self-expandable PDA occluder is a percutaneous trans catheter closure device intended for the occlusion of patent ductus arteriosus defects (PDA). The retention skirt provides secure positioning ...
Comed

The Hyperion PFO Occluder (PFOO) is two discs connected using a short waist, that allow for free, independent motion of each disc. The Occluder has been designed for use in patients who have a history of stroke or transient ischemic attacks ...
Comed

Hyperion™ VSDO Muscular Membranous The VSDO Muscular closure device is available in a with hub design only. The discs are asymmetrical with sizes running from 4.0 to 18 mm. The standard waist length is 7 mm, and a 10 ...
Comed

The oxydized Nitinol VSDO Perimembranous Zero Edge closure device is available in with hub design. The discs are in a special asymmetrical design with sizes running from 4.0 to 16 mm. The LA disc design prohibits interference ...
Comed

The Evermend™ PDA occluder is a percutaneous,transcatheter device especially designed for closure of normally located PDA. The treatment is feasible in the very young pediatric population. The occluder is made of a Nitinol ...
Shanghai Microport Orthopedics

The Evermend™ ASD occluder is designed for the pertutaneous,transcatheter occlusion of secundum arterial spetal defector patient who have to close their Fontan fenestration. The frame of the occluder uses Nitinol wires ...
Shanghai Microport Orthopedics
Your suggestions for improvement:
Receive monthly updates on this section.
Please specify:
Help us improve:
remaining